adr_usa_0504|MITO|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
adr_usa_0504|MITO|1|Stealth BioTherapeutics Corp Total Current Assets (Quarterly) (USD)|Stealth BioTherapeutics Corp Cash and Short Term Investments (Quarterly) (USD)|Stealth BioTherapeutics Corp Inventories (Quarterly) (USD)|Stealth BioTherapeutics Corp Net PP&E (Quarterly) (USD)|Stealth BioTherapeutics Corp Goodwill and Intangibles (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Liabilities (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Current Liabilities (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Long Term Liabilities (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Deposits (Quarterly) (USD)|Stealth BioTherapeutics Corp Book Value (Quarterly) (USD)|Stealth BioTherapeutics Corp Retained Earnings (Quarterly) (USD)|Stealth BioTherapeutics Corp Treasury Stock (Quarterly) (USD)|Stealth BioTherapeutics Corp EV to Revenues|Stealth BioTherapeutics Corp EV to Earnings|Stealth BioTherapeutics Corp EV to Free Cash Flow|Stealth BioTherapeutics Corp EV to Assets (Quarterly)|Stealth BioTherapeutics Corp PS Ratio|Stealth BioTherapeutics Corp PE Ratio|Stealth BioTherapeutics Corp Price to Book Value|Stealth BioTherapeutics Corp PEG Ratio|Stealth BioTherapeutics Corp Debt to Equity Ratio|Stealth BioTherapeutics Corp Dividend Yield|Stealth BioTherapeutics Corp Shareholder Yield (TTM)|Stealth BioTherapeutics Corp Percent of Shares Outstanding Short|Stealth BioTherapeutics Corp Total Receivables (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Payables (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Capital Stock (Quarterly) (USD)|Stealth BioTherapeutics Corp Return on Invested Capital|Stealth BioTherapeutics Corp Quality Ratio Score|Stealth BioTherapeutics Corp Momentum Score|Stealth BioTherapeutics Corp Beta (1Y)|Stealth BioTherapeutics Corp Sustainable Growth Rate (TTM)|Stealth BioTherapeutics Corp Institutional Investor Ownership Percentage|Stealth BioTherapeutics Corp Average Diluted Shares Outstanding (Quarterly)|Stealth BioTherapeutics Corp Total Employees (Annual)|Stealth BioTherapeutics Corp EPS Diluted (Quarterly) (USD)|Stealth BioTherapeutics Corp SG&A Expense (Quarterly) (USD)|Stealth BioTherapeutics Corp Shares Outstanding|Stealth BioTherapeutics Corp Repurchase of Capital Stock (Quarterly) (USD)|Stealth BioTherapeutics Corp Ordinary Shares Number (Quarterly)|Stealth BioTherapeutics Corp Payout Ratio|Stealth BioTherapeutics Corp Quick Ratio (Quarterly)|Stealth BioTherapeutics Corp Normalized Diluted EPS (Quarterly) (USD)|Stealth BioTherapeutics Corp Stock Buybacks (Quarterly) (USD)|Stealth BioTherapeutics Corp Effective Tax Rate (TTM)|Stealth BioTherapeutics Corp Return on Equity|Stealth BioTherapeutics Corp Net Income (TTM) (USD)|Stealth BioTherapeutics Corp Revenue (TTM) (USD)|Stealth BioTherapeutics Corp Dividend Per Share (Quarterly) (USD)|Stealth BioTherapeutics Corp Revenue (Quarterly) (USD)|Stealth BioTherapeutics Corp Gross Profit (Quarterly) (USD)|Stealth BioTherapeutics Corp Pre-Tax Income (Quarterly) (USD)|Stealth BioTherapeutics Corp Net Income (Quarterly) (USD)|Stealth BioTherapeutics Corp Net Interest Income (Quarterly) (USD)|Stealth BioTherapeutics Corp Price (USD)|Stealth BioTherapeutics Corp Total Return Price (USD)|Stealth BioTherapeutics Corp Enterprise Value (USD)|Stealth BioTherapeutics Corp 30-Day Average Daily Volume|Stealth BioTherapeutics Corp 1 Year Price Returns (Daily)|Stealth BioTherapeutics Corp Short Interest|Stealth BioTherapeutics Corp PE Ratio (Forward)|Stealth BioTherapeutics Corp PE Ratio (Forward 1y)|Stealth BioTherapeutics Corp PS Ratio (Forward)|Stealth BioTherapeutics Corp PS Ratio (Forward 1y)|Stealth BioTherapeutics Corp Quarterly EPS Estimates (USD)|Stealth BioTherapeutics Corp Quarterly Revenue Estimates (USD)|Stealth BioTherapeutics Corp Quarterly EPS Surprise|Stealth BioTherapeutics Corp Quarterly Revenue Surprise|Stealth BioTherapeutics Corp Quarterly Actual EPS (USD)|Stealth BioTherapeutics Corp Quarterly Actual Revenue (USD)|Stealth BioTherapeutics Corp Revenue Estimates for Current Fiscal Year (USD)|Stealth BioTherapeutics Corp Revenue Estimates for Next Fiscal Year (USD)|Stealth BioTherapeutics Corp Price Target (USD)|Stealth BioTherapeutics Corp Consensus Recommendation|Stealth BioTherapeutics Corp Price Target Num Estimates|Stealth BioTherapeutics Corp EPS Estimates for Current Fiscal Year (USD)|Stealth BioTherapeutics Corp EPS Estimates for Next Fiscal Year (USD)|Stealth BioTherapeutics Corp Research and Development Expense (Quarterly) (USD)|Stealth BioTherapeutics Corp Reconciled Depreciation (Quarterly) (USD)|Stealth BioTherapeutics Corp Non-Operating Interest Expense (Quarterly) (USD)|Stealth BioTherapeutics Corp Land and Improvements (Quarterly) (USD)|Stealth BioTherapeutics Corp Buildings and Improvements (Quarterly) (USD)|Stealth BioTherapeutics Corp Other Properties (Quarterly) (USD)|Stealth BioTherapeutics Corp Machine, Furniture & Equipment (Quarterly) (USD)||
adr_usa_0504|MITO|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
adr_usa_0504|MITO|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|daily|monthly|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
adr_usa_0504|MITO|5|105.307692308|105.307692308||105.307692308||105.307692308|105.307692308|105.307692308||105.307692308|106.416666667||||1.44444444444|91.2857142857|||1.44570135747|||1.44795783926||15.2253521127||105.307692308|106.416666667|||31.9523809524|30.5217391304||30.5|91.2666666667|365.5|91.2666666667|91.2666666667|37.5925925926||105.307692308|||91.2666666667|91.2857142857|||91.3333333333|||||91.2666666667|91.2666666667|91.2666666667|7|7|6.95569620253|7|1.44181459566|15.2253521127|||1.44841269841|1.44715447154|91.3333333333|91.3333333333|91.2857142857|91.2|91.2857142857|91.2857142857|29.7777777778|30.0882352941|26.1463414634|13.5696202532|26.1463414634|25.5238095238|24.6666666667|91.2666666667|91.3333333333|91.2666666667|||106.416666667|106.416666667||
adr_usa_0504|MITO|6|13|13||13||13|13|13||13|12||||414|7|||442|||759||71||13|12|||21|23||14|15|2|15|15|27||13|||15|7|||12|||||15|15|15|157|157|158|151|507|71|||252|246|12|12|7|5|7|7|36|34|41|79|41|42|39|15|12|15|||12|12||
adr_usa_0504|MITO|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
adr_usa_0504|MITO|201712|5.92|4.1188||0.7959||298.441|24.5946|273.8464||-291.2861|-329.5568|||||||||||||||7.4546|0.0205|||||||20.384||-1.0827|3.5627|||396.221|||-1.0847|||||||||-22.07|-22.07|-1.5405||||||||||||||||||||||||17.0078|0.0849|1.5711|||0.3768|1.0739||
adr_usa_0504|MITO|201803||||||||||||||||||||||||||||||||||20.384||-0.9979|3.496||||||-0.9953|||||||||-20.341|-20.341|-3.356||||||||||||||||||||||||13.436||3.378||||||
adr_usa_0504|MITO|201806||||||||||||||||||||||||||||||||||20.384||-1.3274|4.29||||||-1.0418|||||||||-27.057|-27.057|-4.846||||||||||||||||||||||||12.1||4.905||||||
adr_usa_0504|MITO|201809|5.0301|4.0783||0.5725||44.5209|31.6672|12.8538||-32.8912|-399.6797|||||||||||||||8.8263|0.0881|||||||20.384||-1.1148|4.755|||396.221|||-1.3273||||-92.193|||||-22.725|-22.725|-6.079||||||||||||||||||||||||16.222||6.139|||0.3768|1.0855||
adr_usa_0504|MITO|201812|13.293|10.855||0.499||402.229|40.611|361.618||-386.706|-426.269|||||||||||||0.149||11.023|0.021|||||||33.0184|57|-0.8053|9.676|34.4416||396.221|||-0.8438||||-96.712|||||-26.589|-26.589|-6.881|11.92|11.92|521.7279|||51315||||||||||||||||||11.304|0.0739|6.935|||0.377|1.086||
adr_usa_0504|MITO|201903|72.094|70.497||0.433||38.935|26.48|12.455||33.923|||||||||15.1073|||||0.1313||9.605||||||||18.3363||-2.4|4.157|35.0298||420.3575|||-1.2974||||-119.549|||||-43.178|-43.178|-4.475|13.58|13.58|586.8887|64641.9667||45979||||||||||||11.0577|25.75|2|4|-1.695|-2.2075|14.328||4.683|||||14.6373|12.75
adr_usa_0504|MITO|201906|54.608|53.2||0.437||36.01|25.684|10.326||19.285|||||||||12.9078|||||0.011||8.97||||||||35.0333||-0.48|6.064||||||-0.48||||-108.242|||||-15.75|-15.75|-0.32|12.17|12.17|372.5057|6515.8||3868||||||||||||17.2173|27.6|1.6|5|-0.2325|-0.216|9.366||0.662|||||12.515|8.9
adr_usa_0504|MITO|201909|38.918|37.23||0.421||35.894|27.795|8.099||3.695|||||||||56.6923|||||0.0268||7.284||||||||35.0333||-0.48|6.269|36.392||420.3998|||-0.48|-78.226|||-102.047|||||-16.53|-16.53|-0.441|5.22|5.22|146.4186|16142.9||9393|||||||||||2.5|8.8392|25.6667|1.8333|6|-0.254|-0.2233|9.82||0.664|||||6.32|11.6071
adr_usa_0504|MITO|201912|52.398|50.768||0.345||35.476|33.95|1.526||17.267|-497.997|||||1.5948|||6.8711||0.9406|||0.1385||9.52|0.131||||2.7962|||36.3146|31|0.24|5.825|36.3934||436.7208||1.4954|0.24||||-71.728|||21.087||3.73|3.73|-0.442|3.45|3.45|105.1664|214999.1333|-84.5833|50391|||6.7796||-0.022|9|509.0909|134.3|0.09|21.087|7.5|1.251|7.375|2.5|6|-0.248|-0.1817|11.09|0.076|0.657|||0.377|1.141|2.52|1.85
adr_usa_0504|MITO|202003|31.862|31.242||0.285||29.72|29.72|||2.427||||||0.5407|||18.5941|||||0.0777||6.513||||1|2.364|||36.3934||-0.48|5.18|36.3934||436.7208|||-0.48||||-44.09|||||-15.54|-15.54|-0.513|1.29|1.29|16.0608|1192063.2|-90.3125|28270|||2.5787||-0.0325||-23.0769||-0.04||0.1857|32.2367|7.0417|2.5|6|-0.1383|-0.084|9.847||0.636|||||1.69|2.1201
adr_usa_0504|MITO|202006|32.916|31.834||0.224||22.09|22.09|||11.585|||||-0.3664|1.3115|||7.8201|||||0.0094||5.003||||1|2.9093|||47.9492||-0.24|4.523|49.5061||594.0735|||-0.24|-20|||-40.709|||||-12.369|-12.369|-0.441|1.83|1.83|75.8187|136738.6333|-85.36|4675|||5.1769||-0.025||20||-0.02|||25.6737|3.375|2.2857|4|-0.1125|-0.05|7.405||0.455|||||2.12|1.51
adr_usa_0504|MITO|202009|21.652|19.893||0.169||20.251|20.251|||2.274|-537.116||||-0.3117|1.0703|||29.6217|||||0.1962||3.452|0.179|||1|2.4176||1.2426|49.7417||-0.24|4.671|49.8961||598.7535|||-0.24|-20.673|||-35.389|||||-11.21|-11.21|-0.328|1.35|1.35|56.4487|85941|-77.4247|97916|||3.8491||-0.02||||-0.02||8.75|25.454|3.1875|2.25|4|-0.085|-0.0425|6.211|0.054|0.33|||0.289|1.141|1.5162|1.32
adr_usa_0504|MITO|202012|35.04|32.787||0.106||46.22|21.049|25.171||-10.372|-555.454||||-0.3055|1.0491|||33.3518|||||0.0868||3.526|0.191|||1|2.0855||2.0353|51.2502|29|-0.36|4.992|52.9243||635.0921|||-0.2211||||-57.457|||||-18.338|-18.338|-0.387|1.57|1.57|64.9311|763220.2333|-54.1411|45934|||4.3338|33.6689|-0.02|17.5|-50|-100|-0.03||17.5|33.9387|2.82|2.3333|3|-0.09|-0.0333|5.842|0.042|0.387|||0.289|0.263|1.74|1.81
adr_usa_0504|MITO|202103|33.987|32.06||0.092||46.86|16.206|30.654||-12.079|||||-0.345|1.1849||||||||0.1911||4.62||||2|1.5398||6.32|54.4006||-0.12|4.979|||667.3997|||-0.1878||||-49.606|||||-7.689|-7.689|-0.299|1.47|1.47|62.4941|348905.5333|26.6129|106280||||37.1566|-0.01|5||-100|-0.01||50.4845|8.482|3.5|2|2|-0.025|-0.09|6.099||0.3|||||1.25|1.31
adr_usa_0504|MITO|202106|31.61|30.766||0.072||58.573|13.415|45.158||-26.315|-581.549||||-0.4204|1.2232||||||||0.5616||2.566|0.207|||1|-0.0591||2.6797|56.2382||-0.36|5.083|57.5828||690.9938|||-0.2316|-6.903|||-55.643|||||-18.406|-18.406|-0.187|1.5|1.5|64.5152|3827152.7667|-14.7541|323374||||38.2252|-0.02||-50||-0.03|||1.5667|3.3333|2|3|-0.0667|-0.0767|5.913||0.188|||0.289|0.269|1.35|1.34
adr_usa_0504|MITO|202109|43.44|42.277||0.115||73.019|9.658|63.361||-28.832|||||-0.323|0.94||||||||1.9235||3.915||||2|-0.1564||1.6289|57.7094||-0.12|4.707|57.5828||690.9938|||-0.2126||||-50.73|||||-6.297|-6.297|-0.196|1.36|1.36|52.4228|481229.4|0.7407|1107594||||33.3245|-0.02||16||-0.0168|||2.35|3.5|2|2|-0.06|-0.06|6.739||0.196|||||1.15|0.85
adr_usa_0504|MITO|202112|||||||||||||||-0.1242|||||||||0.1041||||||2|-1.2491||1.6268||||||||||||||||||||||0.7825|0.7825|16.1796|117608.9|-44.4816|59961||||20.5828|-0.02||||||||3|2|1|-0.07|||||||||0.6566|0.5701
adr_usa_0504|MITO|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.02|||||||||||||||||||||
adr_usa_0504|MITO|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.02|||||||||||||||||||||
adr_usa_0504|MITO|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.02|||||||||||||||||||||
adr_usa_0504|MITO|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.01|||||||||||||||||||||